Lulizumab Pegol
Modify Date: 2024-04-05 18:00:11
Lulizumab Pegol structure
|
Common Name | Lulizumab Pegol | ||
|---|---|---|---|---|
| CAS Number | 1421830-13-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Lulizumab PegolLulizumab pegol (BMS-931699) is an anti-CD28 antibody antagonist. Lulizumab pegol effectively inhibits T-cell proliferation and it can be used for the reseach of kidney transplantation and autoimmunity disease[1]. |
| Name | Lulizumab Pegol |
|---|
| Description | Lulizumab pegol (BMS-931699) is an anti-CD28 antibody antagonist. Lulizumab pegol effectively inhibits T-cell proliferation and it can be used for the reseach of kidney transplantation and autoimmunity disease[1]. |
|---|---|
| Related Catalog | |
| In Vitro | BMS-931699 通过生物大分子相互作用分析系统显示出对 T 细胞增殖的 Kd 为 0.41 nM[1]。 BMS-931699 通过混合淋巴细胞反应 (MLR) 诱导的 T 细胞增殖的 EC50 为 2.9 nM 以及对全血中 CD28 受体占用 (RO) 的 EC50 为 4.4 nM[1]。 |
| References |
| No Any Chemical & Physical Properties |